Revance Therapeutics Inc. buy BiotechBee
Start price
03.01.23
/
70%
€17.50
Target price
31.12.25
€30.00
Performance (%)
76.00%
End price
05.05.23
€30.80
Summary
This prediction ended on 05.05.23 with a price of €30.80. With a performance of 76.00% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
According to BiotechBee what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year